CHARTWELL INVESTMENT PARTNERS, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 106 filers reported holding HERON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.

Quarter-by-quarter ownership
CHARTWELL INVESTMENT PARTNERS, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$1,862,000
-23.1%
100,171
+1.1%
0.06%
-21.8%
Q1 2019$2,421,000
+87.1%
99,042
+98.6%
0.08%
+69.6%
Q4 2018$1,294,000
-54.6%
49,882
-44.6%
0.05%
-45.2%
Q3 2018$2,850,000
+21.8%
90,049
+49.5%
0.08%
+20.0%
Q2 2018$2,340,000
+26.6%
60,237
-10.0%
0.07%
+11.1%
Q1 2018$1,848,000
-49.5%
66,955
-66.9%
0.06%
-49.2%
Q4 2017$3,656,000
+56.2%
201,977
+39.3%
0.12%
+55.0%
Q3 2017$2,340,000144,9470.08%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders